Results 81 to 90 of about 2,547 (172)
International Journal of Nanomedicine, 2019 Fan Yang, Run Chang, Thomas J Webster Department of Chemical Engineering, Northeastern University, Boston, MA 02115, USACorrespondence: Thomas J WebsterDepartment of Chemical Engineering, Northeastern University, 313 Snell Engineering Center, 360 ...
Yang F, Chang R, Webster TJ
doaj
Bioresorbable scaffolds in the treatment of coronary artery disease
Medical Devices: Evidence and Research, 2013 Yaojun Zhang,1,2 Christos V Bourantas,1 Vasim Farooq,1 Takashi Muramatsu,1 Roberto Diletti,1 Yoshinobu Onuma,1 Hector M Garcia-Garcia,1 Patrick W Serruys11Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2Division of Cardiovascular ...
Zhang Y +7 more
doaj
Contemporary Drug-Eluting Stents and Vascular Response
European Medical Journal, 2017 Cardiovascular disease is a leading cause of death and disability worldwide. Current treatment strategies aimed at treating the consequences of coronary artery disease have embraced both optimal medical therapy and catheter based percutaneous coronary ...
Anwer Habib +3 more
doaj
The future of bioresorbable stents [PDF]
Intervenční a akutní kardiologie, 2017 openaire +1 more source
Electrospun bioresorbable polymer membranes for coronary artery stents
Frontiers in Bioengineering and BiotechnologyPercutaneous coronary intervention, a common treatment for atherosclerotic coronary artery lesions, occasionally results in perforations associated with increased mortality rates. Stents coated with a bioresorbable polymer membrane may offer an effective solution for sealing coronary artery perforations.
Maria A. Rezvova +9 more
openaire +3 more sources
Risk of stent thrombosis with bioresorbable vascular scaffolds [PDF]
The Lancet, 2016 Rahman, Shah +2 more
openaire +2 more sources
The benefits of drug-eluting stents in the treatment of coronary artery disease
Research Reports in Clinical Cardiology, 2016 Sarkis Kiramijyan,1 Ming W Liu2 1Division of Cardiology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA, USA; 2Heart and Vascular Care Center, White Memorial Medical Center, Los Angeles, CA, USA Abstract: The advent of coronary stents ...
Kiramijyan S, Liu MW
doaj
Bioresorbable Coronary Scaffolds: Current State of Evidence
European Medical Journal Cardiology, 2017 Second-generation drug-eluting stents are currently considered the standard of care in patients undergoing treatment for coronary artery disease with percutaneous coronary intervention.
Sunny Goel +5 more
doaj
Bioresorbable Drug-Eluting Stents
JACC: Cardiovascular Interventions, 2016 Yukinori Harada, Robert A. Byrne
openaire +1 more source